Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
Despite recent advances in tuberculosis (TB) drug development and availability, successful antibiotic treatment is challenged by the parallel development of antimicrobial resistance. As a result, new approaches toward improving TB treatment have been proposed in an attempt to reduce the high TB morb...
Main Authors: | Nelita du Plessis, Leigh A. Kotze, Vinzeigh Leukes, Gerhard Walzl |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2018.00332/full |
Similar Items
-
Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
by: Vinzeigh Leukes, et al.
Published: (2020-03-01) -
The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
by: Tandeka Magcwebeba, et al.
Published: (2019-04-01) -
Corrigendum: The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
by: Tandeka Magcwebeba, et al.
Published: (2019-07-01) -
Evolution of our understanding of myeloid regulatory cells: from MDSCs to Mregs
by: Masoud H Manjili, et al.
Published: (2014-07-01) -
Human Monocytic Suppressive Cells Promote Replication of Mycobacterium tuberculosis and Alter Stability of in vitro Generated Granulomas
by: Neha Agrawal, et al.
Published: (2018-10-01)